Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-02-23 SCANGOS GEORGE A Chief Executive Officer Shares withheld for taxes −1,395 $258.99 $361K 61,417
2016-02-23 SCANGOS GEORGE A Chief Executive Officer Exercise or conversion · Restricted Stock Unit −2,964 23,586
2016-02-23 SCANGOS GEORGE A Chief Executive Officer Other disposition · Restricted Stock Unit −5,884 17,702
2016-02-22 Karaboutis Adriana EVP, Tech, Bus. Sol & Corp Aff Grant or award · Restricted Stock Unit +7,900 7,900
2016-02-22 ALEXANDER SUSAN H EVP, Chief Legal Officer Grant or award · Restricted Stock Unit +7,270 7,270
2016-02-22 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Grant or award · Restricted Stock Unit +7,270 7,270
2016-02-22 Artavanis-Tsakonas Spyridon SVP, Chief Scientific Officer Grant or award · Restricted Stock Unit +6,800 6,800
2016-02-22 DiPietro Kenneth EVP Human Resources Grant or award · Restricted Stock Unit +7,900 7,900
2016-02-22 COVINO GREGORY F VP, Chief Accounting Officer Grant or award · Restricted Stock Unit +870 870
2016-02-22 Clancy Paul J Executive VP and CFO Grant or award · Restricted Stock Unit +11,060 11,060
2016-02-22 Cox John EVP Pharmaceutical Oper & Tech Grant or award · Restricted Stock Unit +11,850 11,850
2016-02-22 SCANGOS GEORGE A Chief Executive Officer Grant or award · Restricted Stock Unit +40,460 40,460
2016-02-22 Koppel Adam EVP, Strategy and Bus. Dev. Grant or award · Restricted Stock Unit +7,270 7,270
2016-02-17 SCANGOS GEORGE A Chief Executive Officer Sale −487 $256.16 $125K 59,848
2015-02-12 SCANGOS GEORGE A Chief Executive Officer Exercise or conversion +9,189 43,466
2015-02-12 SCANGOS GEORGE A Chief Executive Officer Exercise or conversion · Restricted Stock Unit −9,189 18,380

Page 73 of 73 · 1,456 trades